Search Results - Margolis, Jeannine

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    In Vitro Metabolism of CP-122,721 ((2S,3S)-2-Phenyl-3-[(5-Trifluoromethoxy-2-Methoxy)Benzylamino]Piperidine), a Non-Peptide Antagonist of the Substance P Receptor

    In Vitro Metabolism of CP-122,721 ((2S,3S)-2-Phenyl-3-[(5-Trifluoromethoxy-2-Methoxy)Benzylamino]Piperidine), a Non-Peptide Antagonist of the Substance P Receptor by Scott Obach, R., Margolis, Jeannine M., Logman, Michael J.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

    Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia by Reagan, John L., Niroula, Rabin, McMahon, Jessica, Egan, Pamela, Yakirevich, Inna, Pereira, Mandy, Pelcovits, Ari, Margolis, Jeannine, Sturtevant, Ashlee, Quesenberry, Peter J., Fast, Loren D.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Mosunetuzumab with Response-Driven Lenalidomide Augmentation As First-Line Therapy for Symptomatic Follicular or Marginal Zone Lymphoma: Interim Analysis of a Multi-Center Phase 2 Study

    Mosunetuzumab with Response-Driven Lenalidomide Augmentation As First-Line Therapy for Symptomatic Follicular or Marginal Zone Lymphoma: Interim Analysis of a Multi-Center Phase 2... by Olszewski, Adam J., Matasar, Matthew, Huntington, Scott F, Ollila, Thomas, Pelcovits, Ari, Tiger, Yun Kyoung, Reagan, John L., Chorzalska, Anna Dorota, Morgan, John, Pardo, Makayla R, McMahon, Jessica, Donnelly, Stephen, Carmody, Caylee, Margolis, Jeannine, Milrod, Charles, Dubielecka, Patrycja M.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Circulating Biomarkers and CD8+ T-Cell Subpopulations Reveal Evolving Phases of Immune Response in Patients Receiving Mosunetuzumab for Previously Untreated B-Cell Lymphoma

    Circulating Biomarkers and CD8+ T-Cell Subpopulations Reveal Evolving Phases of Immune Response in Patients Receiving Mosunetuzumab for Previously Untreated B-Cell Lymphoma by Milrod, Charles, Chorzalska, Anna Dorota, Morgan, John, Pardo, Makayla R, Raker, Christina, Ollila, Thomas, Lee, Seo-Ho, Pelcovits, Ari, Reagan, John L., McMahon, Jessica, Donnelly, Stephen, Carmody, Caylee, Margolis, Jeannine, Matasar, Matthew, Huntington, Scott F, Dubielecka, Patrycja M., Olszewski, Adam J.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study

    Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study by Ollila, Thomas, Butera, James, Egan, Pamela, Reagan, John, Thomas, Anthony, Yakirevich, Inna, MacKinnon, Kelsey, Margolis, Jeannine, McMahon, Jessica, Rosati, Valerie, Olszewski, Adam J

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Vincristine Sulfate Liposome Injection (VSLI) with Bendamustine and Rituximab As First-Line Therapy for Indolent B-Cell Lymphomas: A Phase 1 Study

    Vincristine Sulfate Liposome Injection (VSLI) with Bendamustine and Rituximab As First-Line Therapy for Indolent B-Cell Lymphomas: A Phase 1 Study by Ollila, Thomas A, Butera, James, Egan, Pamela C, Reagan, John L, Thomas, Anthony G, Yakirevich, Inna, MacKinnon, Kelsey, Margolis, Jeannine, Rosati, Valerie, McMahon, Jessica, Robison, Jordan, Olszewski, Adam J

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    144 - BrUOG 345: Fractionated Gemtuzumab Ozogamicin Followed By Nonengraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

    144 - BrUOG 345: Fractionated Gemtuzumab Ozogamicin Followed By Nonengraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia by Reagan, Dr. John L, Niroula, Rabin, McMahon, Jessica, Papa, Elaine, Egan, Pamela, Yakirevich, Inna, Pelcovits, Ari, Olszewski, Adam J, Margolis, Jeannine, Sturtevant, Ashlee, Quesenberry, Peter, Fast, Loren

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    BrUOG 345: Fractionated Gemtuzumab Ozogamicin Followed By Nonengraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

    BrUOG 345: Fractionated Gemtuzumab Ozogamicin Followed By Nonengraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia by Reagan, Dr. John L, Niroula, Rabin, McMahon, Jessica, Papa, Elaine, Egan, Pamela, Yakirevich, Inna, Pelcovits, Ari, Olszewski, Adam J, Margolis, Jeannine, Sturtevant, Ashlee, Quesenberry, Peter, Fast, Loren

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: